Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Revelation Of Secrets of Lung Cancer Drug Resistance at UCSF | |
|
| |
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty. The uncertainty dawns around the fact that their tumors may initially shrink, it's not a question of whether their cancer will returnit's a question of when. And for far too many, it happens far too soon.
Now, a team of researchers at the University of California, San Francisco's Helen Diller Family Comprehensive Cancer Center has discovered that a human protein called AXL drives resistance to Tarceva, which suggests that blocking the protein may prevent resistance to the cancer drug.
The discovery, described this week in Nature Genetics, may lead to better treatments involving precision medicines that would combine Tarceva with new drugs designed to block AXL.
"If we block AXL activation in the laboratory, we can overcome resistance to Tarceva," said Trever Bivona, MD, PhD, an assistant professor of hematology and oncology. "This paves the way for novel and more effective therapies."
In the experiments, Bivona and his colleagues used an inhibitor of AXL that is not an ideal clinical drug. But now Bivona and his team are working together with Kevan Shokat, PhD, a Howard Hughes Medical Institute Investigator and chair of the UCSF Department of Cellular and Molecular Pharmacology, to develop more potent AXL inhibitors for clinical testing.
Lung Cancer is Number One Cancer Killer
Lung cancer is the most common cause of cancer death worldwide. More people die from the disease each year than from breast, colon and prostate cancers combined. It claims more than 150,000 American lives annually and accounts for some 1.4 million deaths around the world. About 85 percent of Americans with all types of lung cancer die within five years of diagnosis.
Most cases result from exposure to cigarette smoke, but other causes include exposure to asbestos, chemicals, environmental factors and genetic susceptibility.
One thing that makes lung cancer so difficult is that it often goes undetected in its early stages because it usually does not cause symptoms. Only about 30 percent of patients in the United States are detected in the earliest stage of the disease, contributing to its low overall survival rate.
Even people who have their cancer detected at the earliest stages, however, face serious odds. Unlike other types of cancer, where early diagnosis has significant survival advantages, some 35 to 45 percent of people with stage I lung cancer die within five years of recurrent disease.
Source-Eurekalert
| |
|
|
More News on: Drug Toxicity, Lung Biopsy, Lung Cancer, Malignant Mesothelioma, Cancer and Homeopathy, Smoking Risk, Signature Drug Toxicity, Cancer Facts, Asbestosis , Cancer
 Comment & Contribute
|
Related Links
Lung Cancer
Lung cancer is the uncontrolled growth of abnormal cells in the lung. Majority of people who get lung cancer have been cigarette smokers, but not all ...
Lung Cancer Screening - FAQs
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can help in early detection of cancer and possible ...
Health Hazards of Smoking
Information on the Health Hazards of Smoking Cigarettes, and its effect on Blood Pressure, and general health. ...
Cancer Related News
Research Highlights Racial Disparities in the Surgical Management of Non-Small Cell Lung Cancer
A new study has indicated that the surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of ...
Study: 2 Radiotherapy Treatments Show Similar Morbidity, Cancer Control After Prostatectomy
According to a study, use of the newer, more expensive intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) ...
Research: The Compound in the Mediterranean Diet That Makes Cancer Cells 'Mortal'
A compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death, suggests new research. By ...
IMRT may Not be More Effective Than Older Radiation Techniques After Prostatectomy: Research
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer. Despite this, research from the ...
Study Says Grapefruit Nanoparticles can Deliver Anti-cancer Drugs
Engineered nanoparticles derived from grapefruit can be used to deliver anti-cancer and other drugs to tumor cells, say researchers. ...
- Health News Index
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | Less Sleep Associated With Increased Risk of Crashes for Young Drivers: Study |
| » | Need for Avoidance of Sun Exposure Emphasized By Study of Young Israelis |
| » | Research Explains How Bilinguals Switch Between Languages |
| » | Italian Potato Field Witnesses Unveiling Of Pope Statue |
| » | Device That can Charge Phone in 20 Seconds Invented By Indian Girl |
| More Life Style News | |
|
Ask an Expert
